Association of Gestational Weight Gain With Adverse Maternal and Infant Outcomes.


Journal

JAMA
ISSN: 1538-3598
Titre abrégé: JAMA
Pays: United States
ID NLM: 7501160

Informations de publication

Date de publication:
07 05 2019
Historique:
entrez: 8 5 2019
pubmed: 8 5 2019
medline: 29 5 2019
Statut: ppublish

Résumé

Both low and high gestational weight gain have been associated with adverse maternal and infant outcomes, but optimal gestational weight gain remains uncertain and not well defined for all prepregnancy weight ranges. To examine the association of ranges of gestational weight gain with risk of adverse maternal and infant outcomes and estimate optimal gestational weight gain ranges across prepregnancy body mass index categories. Individual participant-level meta-analysis using data from 196 670 participants within 25 cohort studies from Europe and North America (main study sample). Optimal gestational weight gain ranges were estimated for each prepregnancy body mass index (BMI) category by selecting the range of gestational weight gain that was associated with lower risk for any adverse outcome. Individual participant-level data from 3505 participants within 4 separate hospital-based cohorts were used as a validation sample. Data were collected between 1989 and 2015. The final date of follow-up was December 2015. Gestational weight gain. The main outcome termed any adverse outcome was defined as the presence of 1 or more of the following outcomes: preeclampsia, gestational hypertension, gestational diabetes, cesarean delivery, preterm birth, and small or large size for gestational age at birth. Of the 196 670 women (median age, 30.0 years [quartile 1 and 3, 27.0 and 33.0 years] and 40 937 were white) included in the main sample, 7809 (4.0%) were categorized at baseline as underweight (BMI <18.5); 133 788 (68.0%), normal weight (BMI, 18.5-24.9); 38 828 (19.7%), overweight (BMI, 25.0-29.9); 11 992 (6.1%), obesity grade 1 (BMI, 30.0-34.9); 3284 (1.7%), obesity grade 2 (BMI, 35.0-39.9); and 969 (0.5%), obesity grade 3 (BMI, ≥40.0). Overall, any adverse outcome occurred in 37.2% (n = 73 161) of women, ranging from 34.7% (2706 of 7809) among women categorized as underweight to 61.1% (592 of 969) among women categorized as obesity grade 3. Optimal gestational weight gain ranges were 14.0 kg to less than 16.0 kg for women categorized as underweight; 10.0 kg to less than 18.0 kg for normal weight; 2.0 kg to less than 16.0 kg for overweight; 2.0 kg to less than 6.0 kg for obesity grade 1; weight loss or gain of 0 kg to less than 4.0 kg for obesity grade 2; and weight gain of 0 kg to less than 6.0 kg for obesity grade 3. These gestational weight gain ranges were associated with low to moderate discrimination between those with and those without adverse outcomes (range for area under the receiver operating characteristic curve, 0.55-0.76). Results for discriminative performance in the validation sample were similar to the corresponding results in the main study sample (range for area under the receiver operating characteristic curve, 0.51-0.79). In this meta-analysis of pooled individual participant data from 25 cohort studies, the risk for adverse maternal and infant outcomes varied by gestational weight gain and across the range of prepregnancy weights. The estimates of optimal gestational weight gain may inform prenatal counseling; however, the optimal gestational weight gain ranges had limited predictive value for the outcomes assessed.

Identifiants

pubmed: 31063572
pii: 2732571
doi: 10.1001/jama.2019.3820
pmc: PMC6506886
doi:

Types de publication

Journal Article Meta-Analysis Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1702-1715

Subventions

Organisme : British Heart Foundation
ID : RG/15/17/31749
Pays : United Kingdom
Organisme : NIEHS NIH HHS
ID : K12 ES019852
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES023513
Pays : United States
Organisme : NINDS NIH HHS
ID : U01 NS047537
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES001247
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA096525
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK103246
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_12011/4
Pays : United Kingdom
Organisme : NICHD NIH HHS
ID : R01 HD034568
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_00011/6
Pays : United Kingdom
Organisme : FIC NIH HHS
ID : R03 TW007152
Pays : United States
Organisme : Medical Research Council
ID : MC_UP_A620_1017
Pays : United Kingdom
Organisme : NIH HHS
ID : UG3 OD023286
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Acta Paediatr Suppl. 2006 Apr;450:76-85
pubmed: 16817681
Obstet Gynecol. 2007 Oct;110(4):745-51
pubmed: 17906004
Obstet Gynecol. 2007 Oct;110(4):752-8
pubmed: 17906005
Obstet Gynecol. 2007 Oct;110(4):759-64
pubmed: 17906006
Bull World Health Organ. 2007 Sep;85(9):660-7
pubmed: 18026621
Matern Child Health J. 2011 Oct;15(7):860-5
pubmed: 18247109
Am J Epidemiol. 2009 Jul 15;170(2):173-80
pubmed: 19439579
Acta Paediatr Scand. 1991 Aug-Sep;80(8-9):756-62
pubmed: 1957592
Am J Clin Nutr. 2009 Dec;90(6):1552-8
pubmed: 19812177
Am J Clin Nutr. 2011 Nov;94(5):1225-31
pubmed: 21918221
Health Technol Assess. 2012 Jul;16(31):iii-iv, 1-191
pubmed: 22814301
PLoS One. 2013 Apr 16;8(4):e61627
pubmed: 23613888
Obes Rev. 2014 Apr;15(4):338-47
pubmed: 24321007
BMJ. 2014 Feb 10;348:g1285
pubmed: 24513442
JAMA. 2014 Apr 16;311(15):1536-46
pubmed: 24737366
Am J Clin Nutr. 2014 Aug;100(2):701-7
pubmed: 24965305
Lancet Diabetes Endocrinol. 2015 Oct;3(10):767-77
pubmed: 26165396
Eur J Epidemiol. 2015 Nov;30(11):1141-52
pubmed: 26377700
JAMA. 2017 Jun 6;317(21):2207-2225
pubmed: 28586887
BMJ. 2017 Jul 19;358:j3119
pubmed: 28724518
Lancet Child Adolesc Health. 2018 Nov;2(11):812-821
pubmed: 30201470
BMC Med. 2018 Nov 5;16(1):201
pubmed: 30396358
Gynecol Obstet Invest. 1998;46(1):9-16
pubmed: 9692334

Auteurs

Ellis Voerman (E)

Generation R Study Group, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
Department of Pediatrics, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.

Susana Santos (S)

Generation R Study Group, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
Department of Pediatrics, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.

Hazel Inskip (H)

MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, England.
NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, England.

Pilar Amiano (P)

Public Health Division of Gipuzkoa, San Sebastián, Spain.
BioDonostia Research Institute, San Sebastián, Spain.
CIBER Epidemiología y Salud Pública, Madrid, Spain.

Henrique Barros (H)

EPI Unit-Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal.
Department of Public Health and Forensic Sciences and Medical Education, Unit of Clinical Epidemiology, Predictive Medicine and Public Health, University of Porto Medical School, Porto, Portugal.

Marie-Aline Charles (MA)

INSERM, UMR1153 Epidemiology and Biostatistics Sorbonne Paris Cité Center, ORCHAD Team, Villejuif, France.
Paris Descartes University, Villejuif, France.

Leda Chatzi (L)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles.
Department of Social Medicine, Faculty of Medicine, University of Crete, Heraklion, Greece.
Department of Genetics and Cell Biology, Maastricht University, Maastricht, the Netherlands.

George P Chrousos (GP)

First Department of Pediatrics, National and Kapodistrian University of Athens, Medical School, Aghia Sophia Children's Hospital, Athens, Greece.

Eva Corpeleijn (E)

University of Groningen, University Medical Center Groningen, Department of Epidemiology, Groningen, the Netherlands.

Sarah Crozier (S)

MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, England.

Myriam Doyon (M)

Centre de Recherche du Centre Hospitalier de l'Universite de Sherbrooke, Sherbrooke, Quebec, Canada.

Merete Eggesbø (M)

Department of Exposure and Environmental Epidemiology, Norwegian Institute of Public Health, Oslo, Norway.

Maria Pia Fantini (MP)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

Sara Farchi (S)

Department of Epidemiology, Lazio Regional Health Service, Rome, Italy.

Francesco Forastiere (F)

Department of Epidemiology, Lazio Regional Health Service, Rome, Italy.

Vagelis Georgiu (V)

Department of Social Medicine, Faculty of Medicine, University of Crete, Heraklion, Greece.

Davide Gori (D)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

Wojciech Hanke (W)

Department of Environmental Epidemiology, Nofer Institute of Occupational Medicine, Lodz, Poland.

Irva Hertz-Picciotto (I)

Department of Public Health Sciences, School of Medicine, University of California, Davis.

Barbara Heude (B)

INSERM, UMR1153 Epidemiology and Biostatistics Sorbonne Paris Cité Center, ORCHAD Team, Villejuif, France.
Paris Descartes University, Villejuif, France.

Marie-France Hivert (MF)

Centre de Recherche du Centre Hospitalier de l'Universite de Sherbrooke, Sherbrooke, Quebec, Canada.
Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
Diabetes Unit, Massachusetts General Hospital, Boston.

Daniel Hryhorczuk (D)

Center for Global Health, College of Medicine, University of Illinois, Chicago.

Carmen Iñiguez (C)

CIBER Epidemiología y Salud Pública, Madrid, Spain.
Department of Statistics and Computational Research, Universitat de València, València, Spain.

Anne M Karvonen (AM)

Department of Health Security, National Institute for Health and Welfare, Kuopio, Finland.

Leanne K Küpers (LK)

University of Groningen, University Medical Center Groningen, Department of Epidemiology, Groningen, the Netherlands.
Division of Human Nutrition and Health, Wageningen University and Research, Wageningen, the Netherlands.
MRC Integrative Epidemiology Unit, University of Bristol, Bristol, England.
Population Health Science, Bristol Medical School, University of Bristol, Bristol, England.

Hanna Lagström (H)

Department of Public Health, University of Turku, Turku, Finland.

Debbie A Lawlor (DA)

MRC Integrative Epidemiology Unit, University of Bristol, Bristol, England.
Population Health Science, Bristol Medical School, University of Bristol, Bristol, England.

Irina Lehmann (I)

Department of Environmental Immunology/Core Facility Studies, Helmholtz Centre for Environmental Research-UFZ, Leipzig, Germany.

Per Magnus (P)

Division of Health Data and Digitalization, Norwegian Institute of Public Health, Oslo, Norway.

Renata Majewska (R)

Department of Epidemiology, Jagiellonian University Medical College, Krakow, Poland.

Johanna Mäkelä (J)

Turku Centre for Biotechnology, University of Turku and Abo Akademi University, Turku, Finland.

Yannis Manios (Y)

Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, Athens, Greece.

Monique Mommers (M)

Department of Epidemiology, Care and Public Health Research Institute, Maastricht University, Maastricht, the Netherlands.

Camilla S Morgen (CS)

National Institute of Public Health, University of Southern Denmark, Copenhagen.
Department of Public Health, Section of Epidemiology, University of Copenhagen, Copenhagen, Denmark.

George Moschonis (G)

Department of Dietetics, Nutrition, and Sport, La Trobe University, Melbourne, Australia.

Ellen A Nohr (EA)

Research Unit for Gynaecology and Obstetrics, Institute for Clinical Research, University of Southern Denmark, Odense.

Anne-Marie Nybo Andersen (AM)

Department of Public Health, Section of Epidemiology, University of Copenhagen, Copenhagen, Denmark.

Emily Oken (E)

Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, Massachusetts.

Agnieszka Pac (A)

Department of Epidemiology, Jagiellonian University Medical College, Krakow, Poland.

Eleni Papadopoulou (E)

Department of Environmental Exposures and Epidemiology, Domain of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.

Juha Pekkanen (J)

Department of Health Security, National Institute for Health and Welfare, Kuopio, Finland.
Department of Public Health, University of Helsinki, Helsinki, Finland.

Costanza Pizzi (C)

Department of Medical Sciences, University of Turin, Turin, Italy.

Kinga Polanska (K)

Department of Environmental Epidemiology, Nofer Institute of Occupational Medicine, Lodz, Poland.

Daniela Porta (D)

Department of Epidemiology, Lazio Regional Health Service, Rome, Italy.

Lorenzo Richiardi (L)

Department of Medical Sciences, University of Turin, Turin, Italy.

Sheryl L Rifas-Shiman (SL)

Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, Massachusetts.

Nel Roeleveld (N)

Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.

Luca Ronfani (L)

Institute for Maternal and Child Health-IRCCS Burlo Garofolo, Trieste, Italy.

Ana C Santos (AC)

EPI Unit-Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal.
Department of Public Health and Forensic Sciences and Medical Education, Unit of Clinical Epidemiology, Predictive Medicine and Public Health, University of Porto Medical School, Porto, Portugal.

Marie Standl (M)

Institute of Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.

Hein Stigum (H)

Department of Noncommunicable Diseases, Norwegian Institute of Public Health, Oslo, Norway.

Camilla Stoltenberg (C)

Norwegian Institute of Public Health, Oslo, Norway.
Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.

Elisabeth Thiering (E)

Institute of Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.
Dr von Hauner Children's Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.

Carel Thijs (C)

Department of Epidemiology, Care and Public Health Research Institute, Maastricht University, Maastricht, the Netherlands.

Maties Torrent (M)

Ib-Salut, Area de Salut de Menorca, Palma, Spain.

Tomas Trnovec (T)

Department of Environmental Medicine, Slovak Medical University, Bratislava, Slovakia.

Marleen M H J van Gelder (MMHJ)

Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Radboud Reshape Innovation Center, Radboud University Medical Center, Nijmegen, the Netherlands.

Lenie van Rossem (L)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Andrea von Berg (A)

Research Institute, Department of Pediatrics, Marien-Hospital Wesel, Wesel, Germany.

Martine Vrijheid (M)

CIBER Epidemiología y Salud Pública, Madrid, Spain.
ISGlobal, Institute for Global Health, Barcelona, Spain.
Universitat Pompeu Fabra, Barcelona, Spain.

Alet Wijga (A)

National Institute for Public Health and the Environment, Bilthoven, the Netherlands.

Oleksandr Zvinchuk (O)

Department of Medical and Social Problems of Family Health, Institute of Pediatrics, Obstetrics and Gynecology, Kyiv, Ukraine.

Thorkild I A Sørensen (TIA)

Department of Public Health, Section of Epidemiology, University of Copenhagen, Copenhagen, Denmark.
Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Keith Godfrey (K)

MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, England.
NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, England.

Vincent W V Jaddoe (VWV)

Generation R Study Group, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
Department of Pediatrics, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
Department of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.

Romy Gaillard (R)

Generation R Study Group, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
Department of Pediatrics, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH